Evidence map›Paper›PMID 34160843›Full record

SynthesisClinical endocrinology2022

Association of vitamin D deficiency with COVID-19 infection severity: Systematic review and meta-analysis.

Zhen Wang, Avni Joshi, Kaitlin Leopold, Sarah Jackson, Stephanie Christensen, Tarek Nayfeh, Khaled Mohammed, Ana Creo, Peter Tebben, Seema Kumar

2 registry-linked trialsOpen access · bronzeAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Clinical endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 63 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 7 pooled it
14.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05415254 naunknown statusnot on this map

A Randomized Open Label Study to Evaluate Efficacy of Calcitriol Supplementation in COVID-19 Patients With Vitamin D Deficiency

TypeinterventionalSponsorRenJi HospitalRan2022 to 2022Enrolled86ConditionsCOVID-19, Vitamin D DeficiencyArmsCalcitriol
NCT06279910 completednot on this mapstarted 2024, after this paper: background citation

Inclusion of Calcifediol in the Hospital Therapeutic Protocol for Treatment of SARS-CoV-2 Disease (COVID-19). Mortality Analysis. Retrospective Study.

TypeobservationalSponsorComplejo Hospitalario Universitario de AlbaceteRan2024 to 2024Enrolled230ConditionsSARS-CoV 2 PneumoniaArmsCalcifediol
3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 7 syntheses or guidelines pooled it, 109 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Observational
  16. Review
  17. Article
  18. Article
  19. Article
  20. Observational

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Zhen WangDivision of Health Care Delivery Research, Robert D. and Patricia E. Kern Center for the Science of Health Care Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA.
Avni JoshiDivision of Allergic Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Kaitlin LeopoldDepartment of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Sarah JacksonDivision of Pediatric Endocrinology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Stephanie ChristensenDepartment of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Tarek NayfehDivision of Health Care Delivery Research, Robert D. and Patricia E. Kern Center for the Science of Health Care Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA.
Khaled MohammedCommunity Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Ana CreoDivision of Pediatric Endocrinology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0002-4513-1800
Peter TebbenDivision of Pediatric Endocrinology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Seema KumarDivision of Pediatric Endocrinology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0001-8004-4924
Mayo Clinic · USMayo Clinic in Arizona · USMayo Clinic in Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe sought to evaluate the association between vitamin D deficiency and the severity of coronavirus disease 2019 (COVID-19) infection.

methodsMultiple databases from 1 January 2019 to 3 December 2020 were searched for observational studies evaluating the association between vitamin D deficiency and severity of COVID-19 infection. Independent reviewers selected studies and extracted data for the review. The main outcomes of interest were mortality, hospital admission, length of hospital stay and intensive care unit admission.

resultsSeventeen observational studies with 2756 patients were included in the analyses. Vitamin D deficiency was associated with significantly higher mortality (odds ratio [OR]: 2.47, 95% confidence interval [CI]: 1.50-4.05; 12 studies; hazard ratio [HR]: 4.11, 95% CI: 2.40-7.04; 3 studies), higher rates of hospital admissions (OR: 2.18, 95% CI: 1.48-3.21; 3 studies) and longer hospital stays (0.52 days; 95% CI: 0.25-0.80; 2 studies) as compared to nonvitamin D deficient status. Subgroup analyses based on different cut-offs for defining vitamin D deficiency, study geographic locations and latitude also showed similar trends.

conclusionsVitamin D deficiency is associated with greater severity of COVID-19 infection. Further studies are warranted to determine if vitamin D supplementation can decrease the severity of COVID-19.

Indexed as

COVID-19Vitamin D DeficiencyHumansIntensive Care UnitsSARS-CoV-2Vitamin DVitamin DCOVID-19hospital admissionmortalityvitamin D

Identifiers

PMID34160843
PMCPMC8444883
OpenAlexW3177232264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.